Portfolio comparison
University of Pennsylvania Penn vs Immatics Biotechnologies
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
University of Pennsylvania Penn
Patents indexed
4
Year range
2012 – 2024
Most recent
2024
How Modified RNA Tricks Cells Into Making Proteins Without Triggering Attacks
How Genetically Modified T-Cells Fight CD19 Cancers
How Genetically Modified T-Cells Attack Cancer
Activity by Decade
Company B
Immatics Biotechnologies
Patents indexed
3
Year range
2019 – 2024
Most recent
2024
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
Treating Liver Cancer with Specially Trained Immune Cells
How a Specific Peptide Boosts the Immune System Against Cancer
Activity by Decade
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.